TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $11.99M2017: $15.21M2018: $15.36M2019: $16.66M2020: $52.46M2022: $87.22M2023: $83.78M2024: $77.91M2025: $74.56M$74.56M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$74.56M-4.3%
2024$77.91M-7.0%
2023$83.78M-3.9%
2022$87.22M—
2020$52.46M+214.9%
2019$16.66M+8.5%
2018$15.36M+0.9%
2017$15.21M+26.9%
2016$11.99M—